8 news items
Zomedica Secures CE Certification for VetGuardian, Expanding Access to Contactless Monitoring for Vets in the EU
ZOM
6 May 24
EU health, safety, and environmental protection standards. Importantly, this significant milestone expands the market size for VetGuardian
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
ZOM
6 May 24
that the VetGuardian system meets all EU health, safety, and environmental protection standards. Importantly, this significant milestone expands
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
ZOM
2 May 24
infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ZOM
1 Apr 24
approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, including our ability
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
ZOM
14 Mar 24
approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related
g5jgu2m2w2vy8p8w x4hvino4la3lpfqza7ugtr35ezi6zunz68
ZOM
13 Mar 24
relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic
42r63q7y4w he2nvt3noqme8kmmp
ZOM
12 Mar 24
approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID
69z 646m0wdrvsw7vjfomi5veobwgpdrw7dvtqekpaudz5bi3s62rz2xjc16
ZOM
7 Mar 24
to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products
- Prev
- 1
- Next